These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 31548437

  • 21. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z, Weng F, Li C, Shi H, Tang Z, Qiu H, He Y, Wu R, Chu M.
    BMC Pediatr; 2018 Feb 21; 18(1):76. PubMed ID: 29466965
    [Abstract] [Full Text] [Related]

  • 22. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Feb 21; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 23. The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan.
    Kuwabara M, Yashiro M, Ae R, Yanagawa H, Nakamura Y.
    Int J Cardiol; 2018 Oct 15; 269():334-338. PubMed ID: 30049499
    [Abstract] [Full Text] [Related]

  • 24. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 15; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 25. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
    [Abstract] [Full Text] [Related]

  • 26. Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.
    Zheng X, Li J, Yue P, Liu L, Li J, Zhou K, Hua Y, Li Y.
    PLoS One; 2021 Jul 19; 16(3):e0248812. PubMed ID: 33764989
    [Abstract] [Full Text] [Related]

  • 27. Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017.
    Kim GB, Eun LY, Han JW, Kim SH, Yoon KL, Han MY, Yu JJ, Choi JW, Rhim JW.
    Pediatr Infect Dis J; 2020 Nov 19; 39(11):1012-1016. PubMed ID: 33075217
    [Abstract] [Full Text] [Related]

  • 28. Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002.
    Huang GY, Ma XJ, Huang M, Chen SB, Huang MR, Gui YH, Ning SB, Zhang TH, Du ZD, Yanagawa H, Kawasaki T.
    J Epidemiol; 2006 Jan 19; 16(1):9-14. PubMed ID: 16369103
    [Abstract] [Full Text] [Related]

  • 29. Incidence of coronary artery lesions in children with recurrent Kawasaki disease.
    Chen X, Gao L, Zhen Z, Wang Y, Na J, Yu W, Tian Z, Yuan Y, Qian S.
    Expert Rev Clin Immunol; 2024 Jun 19; 20(6):673-678. PubMed ID: 38315096
    [Abstract] [Full Text] [Related]

  • 30. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
    [Abstract] [Full Text] [Related]

  • 31. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
    Suzuki T, Kakimoto N, Tsuchihashi T, Suenaga T, Takeuchi T, Shibuta S, Kitano N, Suzuki H.
    Eur J Pediatr; 2021 Sep 02; 180(9):2797-2805. PubMed ID: 33763715
    [Abstract] [Full Text] [Related]

  • 32. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug 02; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 33. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 02; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 34. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 35. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
    Zhang H, Zhang Y.
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 May 15; 26(5):461-468. PubMed ID: 38802905
    [Abstract] [Full Text] [Related]

  • 36. Retrospective evaluation of 130 cases with kawasaki disease follow-up in a tertiary care center in Turkey between 1999 and 2019: a 20-year experience.
    Topçu U, Sahin N, Kayabey Ö, Babaoğlu K.
    Postgrad Med; 2024 Mar 15; 136(2):189-197. PubMed ID: 38420903
    [Abstract] [Full Text] [Related]

  • 37. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 15; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 38. Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children With Kawasaki Disease.
    Chidambaram AC, Ramamoorthy JG, Anantharaj A.
    Indian Pediatr; 2023 Mar 15; 60(3):207-211. PubMed ID: 36604937
    [Abstract] [Full Text] [Related]

  • 39. Assessment of risk factors for Korean children with Kawasaki disease.
    Kim JJ, Hong YM, Yun SW, Han MK, Lee KY, Song MS, Lee HD, Kim DS, Sohn S, Ha KS, Hong SJ, Kim KJ, Park IS, Jang GY, Lee JK, Korean Kawasaki Disease Genetics Consortium.
    Pediatr Cardiol; 2012 Apr 15; 33(4):513-20. PubMed ID: 22105492
    [Abstract] [Full Text] [Related]

  • 40. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
    Pediatr Infect Dis J; 2008 Feb 15; 27(2):155-60. PubMed ID: 18174868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.